N
3.50
-0.14 (-3.85%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | NovaBridge Biosciences | - | - |
AIStockmoo Score
-0.9
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.88 |
|
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ariose Capital Management Ltd | 31 Dec 2025 | 1,363,515 |
| Exome Asset Management Llc | 31 Dec 2025 | 499,587 |
| Aihc Capital Management Ltd | 31 Dec 2025 | 413,979 |
| 52 Weeks Range | ||
| Median | 9.00 (157.14%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 06 Feb 2026 | 9.00 (157.14%) | Buy | 3.70 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Jan 2026 | Announcement | NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei |
| 06 Jan 2026 | Announcement | NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer |
| 30 Dec 2025 | Announcement | NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |